Glenn A. Oclassen
2010
In 2010, Glenn A. Oclassen earned a total compensation of $1.4M as President and Chief Executive Officer at Paratek Pharmaceuticals, a 109% increase compared to previous year.
Compensation breakdown
| Option Awards | $988,966 |
|---|---|
| Salary | $405,000 |
| Total | $1,393,966 |
Oclassen received $989K in option awards, accounting for 71% of the total pay in 2010.
Oclassen also received $405K in salary.
Rankings
In 2010, Glenn A. Oclassen's compensation ranked 4,193rd out of 10,439 executives tracked by ExecPay. In other words, Oclassen earned more than 59.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,193 out of 10,439 | 60th |
Division Manufacturing | 1,482 out of 3,838 | 61st |
Major group Chemicals And Allied Products | 293 out of 926 | 68th |
Industry group Drugs | 161 out of 685 | 77th |
Industry Pharmaceutical Preparations | 126 out of 481 | 74th |
Source: SEC filing on April 24, 2012.
Oclassen's colleagues
We found five more compensation records of executives who worked with Glenn A. Oclassen at Paratek Pharmaceuticals in 2010.
2010
Thomas Soloway
Paratek Pharmaceuticals
Chief Financial Officer
2010
Nikhilesh Singh
Paratek Pharmaceuticals
Chief Scientific Officer
2010
Terrence Moore
Paratek Pharmaceuticals
Vice President, Sales and Marketing
2010
Joseph Kennedy
Paratek Pharmaceuticals
General Counsel
2010
Marilyn Wortzman
Paratek Pharmaceuticals